Literature DB >> 8586515

Management of testicular cancer with combined-modality treatment.

M Lekili1, S Minareci, N Nergis, U Serim, A R Ayder.   

Abstract

Thirty consecutive patients with germinal testis tumours were treated with combined-modality programme. Seven patients were entered in the surveillance protocol, 7 patients had irradiation of the paraaortic and ipsilateral pelvic lymph nodes, 16 patients were treated with four courses of chemotherapy. Of the patients 5 underwent surgical removal of residual masses. After the combined-modality treatment 27 (90%) patients had complete remission, 2 patients showed progression on therapy and the other had incomplete resection of residual masses. After a median follow-up period of 41.5 months, 27 (90%) remain continuously disease-free, 2 patients died and one patient is still alive with his enlarged mediastinal lymph nodes. The treatment policy stage by stage was defined by the current roles of surgery, irradiation and chemotherapy in our efforts.

Entities:  

Mesh:

Year:  1995        PMID: 8586515     DOI: 10.1007/bf02550078

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Are lymphangiograms necessary before placing patients with nonseminomatous testicular tumors on surveillance?

Authors:  K I Wishnow; D E Johnson; D Tenney
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

Review 2.  The current management of testicular cancer.

Authors:  M Ellis; K Sikora
Journal:  Br J Urol       Date:  1987-01

3.  Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.

Authors:  L S Freedman; M C Parkinson; W G Jones; R T Oliver; M J Peckham; G Read; E S Newlands; C J Williams
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

4.  Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis.

Authors:  R T Oliver; H F Hope-Stone; J P Blandy
Journal:  Br J Urol       Date:  1983-12

Review 5.  Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.

Authors:  B A Lowe
Journal:  Urol Clin North Am       Date:  1993-02       Impact factor: 2.241

6.  Combined management of malignant teratoma of the testis.

Authors:  M J Peckham; T J McElwain; A Barrett; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

7.  Tumor markers in testis cancer.

Authors:  E A Klein
Journal:  Urol Clin North Am       Date:  1993-02       Impact factor: 2.241

8.  The increasing incidence of testicular cancer in East Anglia.

Authors:  A B Nethersell; L K Drake; K Sikora
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

9.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Authors:  M J Peckham; A Barrett; K H Liew; A Horwich; B Robinson; H J Dobbs; T J McElwain; W F Hendry
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.